Global Cholesterol Tests Market 2022 - Snapshot

September 2022 | 44 pages | ID: G3C5FC5485B1EN
Gen Consulting Company

Abstracts

The global cholesterol tests market was estimated at USD 1,585 million in 2021 and is expected to hit USD 2,496 million by 2028, registering a CAGR of 6.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on cholesterol tests can be segmented by product: high-density lipoprotein (HDL) tests, lipid profile, low-density lipoprotein (LDL) tests, point-of-care tests (POCT), total cholesterol tests, triglyceride tests. The lipid profile segment held the largest revenue share in 2021. Cholesterol tests market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2021.

The global cholesterol tests market is highly competitive. The key players in the cholesterol tests market include Abbott Laboratories Inc., Danaher Corp., Horiba Ltd., Mindray Medical International Limited, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Holding AG, Sekisui Diagnostics LLC, Siemens Healthineers, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Cholesterol Tests Market
• Identify segments/areas to invest in over the forecast period in the Global Cholesterol Tests Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. CHOLESTEROL TESTS MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

High-density lipoprotein (HDL) tests
Lipid profile
Low-density lipoprotein (LDL) tests
Point-of-care tests (POCT)
Total cholesterol tests
Triglyceride tests

PART 5. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 6. KEY COMPANIES

Abbott Laboratories, Inc.
Danaher Corp.
Horiba Ltd.
Mindray Medical International Limited
Ortho Clinical Diagnostics, Inc.
Randox Laboratories Ltd.
Roche Holding AG
Sekisui Diagnostics, LLC
Siemens Healthineers
Thermo Fisher Scientific, Inc.

PART 7. METHODOLOGY